文献速递糖尿病

整合糖组学与遗传学分析揭示血浆蛋白和IgG的N-糖基化及补体系统在1型糖尿病发生中的潜在作用

Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes.
PubMed 文献 · Diabetologia · 2023-03-13

研究对丹麦儿童和青少年糖尿病登记中1105例新发1型糖尿病患者的183546个遗传标记进行基因分型,分析与24个IgG和39个血浆蛋白N-聚糖特征的关联,并在455份样本中验证。研究确认了已知位点,发现IgG结合聚糖与染色体22上MGAT3附近SNP的新关联,以及补体C3基因SNP与寡甘露糖血浆蛋白N-聚糖的关联。

要点

  • 新发1型糖尿病患儿中,IgG结合聚糖与染色体22上MGAT3附近两个基因组区间SNP相关。
  • 补体C3基因错义SNP rs1047286和同义SNP rs2230203与寡甘露糖血浆蛋白N-聚糖相关。
  • 研究提示N-糖基化可能影响补体激活和1型糖尿病易感性,需进一步探索。

核心结论

  • 本研究识别了驱动1型糖尿病发病时血浆蛋白和IgG独特N-糖基化的新遗传关联。
  • 结果强调需进一步探索N-糖基化的潜在作用及其对补体激活和1型糖尿病易感性的影响。

研究设计与样本

  • 研究纳入丹麦儿童和青少年糖尿病登记中1105例新发1型糖尿病患者,对183546个遗传标记进行基因分型。
  • 分析这些标记与24个IgG和39个血浆蛋白N-聚糖特征变水平的遗传关联,并在455份样本中验证显著关联。

主要发现

  • 确认了已知血浆蛋白和/或IgG N-糖基化位点,候选基因包括MGAT3、MGAT5和ST6GAL1。
  • 发现IgG结合聚糖与染色体22上靠近候选基因MGAT3的两个基因组区间SNP的新关联,包括含平分型N-乙酰葡糖胺(GlcNAc)的核心岩藻糖基化二半乳糖基化二唾液酸IgG N-聚糖(top SNP rs5757680:p发现=7.65×10^-12,p验证=8.33×10^-6)和含平分型GlcNAc的核心岩藻糖基化二半乳糖基化聚糖(top SNP rs137702:p发现=2.88×10^-10,p验证=3.03×10^-3)。
  • IgG结合聚糖最显著的遗传关联为与MGAT3的关联。
  • 染色体19上补体C3基因(C3)蛋白编码区两个高度连锁不平衡SNP(错义rs1047286和同义rs2230203)与寡甘露糖血浆蛋白N-聚糖相关(top SNP rs1047286:p发现=2.43×10^-11,p验证=8.66×10^-4)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We previously demonstrated that N-glycosylation of plasma proteins and IgGs is different in children with recent-onset type 1 diabetes compared with their healthy siblings. To search for genetic variants contributing to these changes, we undertook a genetic association study of the plasma protein and IgG N-glycome in type 1 diabetes. METHODS: A total of 1105 recent-onset type 1 diabetes patients from the Danish Registry of Childhood and Adolescent Diabetes were genotyped at 183,546 genetic markers, testing these for genetic association with variable levels of 24 IgG and 39 plasma protein N-glycan traits. In the follow-up study, significant associations were validated in 455 samples. RESULTS: This study confirmed previously known plasma protein and/or IgG N-glycosylation loci (candidate genes MGAT3, MGAT5 and ST6GAL1, encoding beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase and ST6 beta-galactoside alpha-2,6-sialyltransferase 1 gene, respectively) and identified novel associations that were not previously reported for the general European population. First, novel genetic associations of IgG-bound glycans were found with SNPs on chromosome 22 residing in two genomic intervals close to candidate gene MGAT3; these include core fucosylated digalactosylated disialylated IgG N-glycan with bisecting N-acetylglucosamine (GlcNAc) (pdiscovery=7.65 × 10-12, preplication=8.33 × 10-6 for the top associated SNP rs5757680) and core fucosylated digalactosylated glycan with bisecting GlcNAc (pdiscovery=2.88 × 10-10, preplication=3.03 × 10-3 for the top associated SNP rs137702). The most significant genetic associations of IgG-bound glycans were those with MGAT3. Second, two SNPs in high linkage disequilibrium (missense rs1047286 and synonymous rs2230203) located on chromosome 19 within the protein coding region of the complement C3 gene (C3) showed association with the oligomannose plasma protein N-glycan (pdiscovery=2.43 × 10-11, preplication=8.66 × 10-4 for the top associated SNP rs1047286). CONCLUSIONS/INTERPRETATION: This study identified novel genetic associations driving the distinct N-glycosylation of plasma proteins and IgGs identified previously at type 1 diabetes onset. Our results highlight the importance of further exploring the potential role of N-glycosylation and its influence on complement activation and type 1 diabetes susceptibility.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Rudman N, Kaur S, Simunović V, et al. Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes. Diabetologia. 2023. PMID: 36907892. doi:10.1007/s00125-023-05881-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。